Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”

  1. 1Institute of Genetics and Biophysics ‘Adriano Buzzati-Traverso’ (IGB), CNR, 80131 Naples, Italy

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is the predominant histological form of pancreatic cancer and remains one of the most aggressive and therapeutically challenging malignancies [...]

Related

  1. Stem Cell-Based Therapies in Companion Animals: Molecular Mechanisms, Clinical Applications, and Translational Perspectives
    Weina Liu, Yu Wang, Wei An +7
    CellsPeer-reviewedCC BY 4.0Full textHuman geneticsCrossrefEurope PMC
  2. Ketogenic Dietary Therapies and β-Hydroxybutyrate as Modulators of Mitochondrial Function: From Molecular Mechanisms to Clinical Translation
    Ji-Hoon Na, Young-Mock Lee
    NutrientsPeer-reviewedCC BY 4.0PhysiologyCrossref
  3. Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis.
    Yi-Chen Li, Jui-Ting Hsu, Chung-Ming Fu +13
    Pharmaceuticals (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Molecular mechanisms by which the intratumoral microbiome drives pancreatic ductal adenocarcinoma progression and therapeutic response
    Zhonghua Qi, Miaolei Wang, Yajing Li +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  5. Biliary and Pancreatic Safety of Incretin-Based Therapies in Obesity and Type 2 Diabetes: A Propensity-Matched Real-World Comparison of Tirzepatide, Semaglutide, and DPP-4 Inhibitors
    Wissam Ghusn, Sasha-Jane Abi-Aad, Maria Daniela Hurtado
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
BibTeX
@article{vilardo2026special,
  title = {{Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”}},
  author = {Claudia Vilardo and Annalisa Di Domenico and Donatella Delle Cave},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = sep,
  doi = {10.3390/ijms27198735},
  url = {https://www.mdpi.com/1422-0067/27/19/8735},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Special Issue “Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition”
AU  - Claudia Vilardo
AU  - Annalisa Di Domenico
AU  - Donatella Delle Cave
PY  - 2026
DA  - 2026/09/30
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27198735
UR  - https://www.mdpi.com/1422-0067/27/19/8735
AB  - Pancreatic ductal adenocarcinoma (PDAC) is the predominant histological form of pancreatic cancer and remains one of the most aggressive and therapeutically challenging malignancies [...]
SN  - 1422-0067
ER  -